Humalog Injection, Suspension
Product Images NDC 0002-8798

43 FDA label images from Eli Lilly And Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Humalog (NDC 0002-8798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Primary Structure (Humalog Mix5050 Uspi Chem V1)

Primary Structure (Humalog Mix5050 Uspi Chem V1)
Chemical structure diagram showing the amino acid sequences of the A-Chain and B-Chain of a peptide or protein. The chains are represented as sequences of labeled and numbered connected circles indicating individual amino acids.*
FDA Label Image

Figure 1 (Humalog Mix5050 Uspi F1 V2)

Figure 1 (Humalog Mix5050 Uspi F1 V2)
A line graph showing glucose infusion rate (mg/min/kg) over time (hours) for different insulin formulations: Humalog U-100, Humalog Mix50/50, Humalog Mix75/25, and ILPS. The graph compares their glucose infusion rates up to 24 hours, illustrating variations in glucose metabolism among the insulin types.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 1 V2)

Figure (Humalogmix50 Vial Ifu 1 V2)
Humalog Mix50/50 injectable suspension 100 units per mL (U-100) vial with a protective cap and rubber stopper beneath the cap. The vial is labeled with the proprietary name and manufacturer Eli Lilly and Company.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 2 V1)

Figure (Humalogmix50 Vial Ifu 2 V1)
Illustration of a syringe showing labeled parts including needle shield, needle, plunger tip, syringe body, and plunger. The syringe body has a clear dose scale from 0 to 100 units, with an example dose of 20 units highlighted at the plunger tip and magnified to show the markings clearly.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 3 V1)

Figure (Humalogmix50 Vial Ifu 3 V1)
An instructional illustration showing hands holding a medicine vial while rotating it gently back and forth, suggesting how to mix or reconstitute the medication before use.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 4 V1)

Figure (Humalogmix50 Vial Ifu 4 V1)
An instructional illustration showing a hand holding a small vial. Arrows indicate a back-and-forth motion, suggesting the vial should be gently shaken or rolled before use.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 5 V1)

Figure (Humalogmix50 Vial Ifu 5 V1)
A black and white instructional illustration showing a hand holding a vial with another hand holding and inverting the vial. The image demonstrates the step of mixing or preparing the medication by turning the vial upside down.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 6 V1)

Figure (Humalogmix50 Vial Ifu 6 V1)
An instructional line drawing showing two hands holding a small vial, with one hand grasping the vial and the other hand removing or placing a cap on it. The image demonstrates the proper technique for handling a vial.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 7 V1)

Figure (Humalogmix50 Vial Ifu 7 V1)
An instructional illustration showing two hands manipulating a syringe. The image depicts the process of drawing medication into the syringe from a vial, indicated by a downward arrow. A close-up of the syringe barrel shows measurement markings up to 40 units.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 8 V1)

Figure (Humalogmix50 Vial Ifu 8 V1)
An instructional diagram showing two hands preparing a syringe with medication. One hand holds a vial, while the other hand inserts the syringe needle into the vial, as indicated by an arrow pointing downward.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 9 V1)

Figure (Humalogmix50 Vial Ifu 9 V1)
An instructional illustration showing a hand holding a vial and another hand drawing liquid from the vial into a syringe. The image includes an arrow indicating the direction of the syringe plunger being pulled back to draw the liquid.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 10 V1)

Figure (Humalogmix50 Vial Ifu 10 V1)
An instructional illustration showing a hand holding a vial and drawing liquid into a syringe. The insert shows a syringe with volume markings from 10 to 40 units, indicating measurement during the process. The diagram conceptually depicts how to prepare a dose by withdrawing medication from a vial with a syringe.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 11 V1)

Figure (Humalogmix50 Vial Ifu 11 V1)
An instructional line drawing showing a person drawing liquid from a vial into a syringe. The image depicts hand positioning and the technique used in preparing an insulin injection, relevant to Humalog Mix50/50.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 12 V1)

Figure (Humalogmix50 Vial Ifu 12 V1)
An instructional illustration showing a hand drawing liquid from a vial into an insulin syringe. The syringe is marked with measurement units from 0 to 40, with a close-up inset highlighting the syringe markings. Arrows indicate the upward motion to fill the syringe.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 13 V1)

Figure (Humalogmix50 Vial Ifu 13 V1)
An instructional illustration showing a hand holding a syringe injecting into the forearm. Another hand holds a small vial, indicating the preparation or administration of an injectable medication.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 14 V1)

Figure (Humalogmix50 Vial Ifu 14 V1)
An instructional anatomical diagram showing recommended injection sites on the human body. The front view indicates areas on the abdomen and outer thighs, while the rear view highlights the upper buttocks areas. This illustration is used to demonstrate where to inject Humalog Mix50/50 insulin.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 15 V1)

Figure (Humalogmix50 Vial Ifu 15 V1)
An instructional illustration showing a person administering an injection into the abdomen area. One hand is holding a syringe, and the other is pinching the skin on the abdomen, with an arrow indicating the direction of injection.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 16 V1)

Figure (Humalogmix50 Vial Ifu 16 V1)
An instructional illustration showing a person using a syringe to inject medication into the upper thigh area. The image depicts hand positioning for the injection process, typically related to subcutaneous administration.*
FDA Label Image

Figure (Humalogmix50 Vial Ifu 17 V1)

Figure (Humalogmix50 Vial Ifu 17 V1)
An instructional illustration showing a person injecting medication with a syringe into the lower abdominal area, demonstrating proper injection technique.*
FDA Label Image

Figure (Humalogmix50 Ifu Qr)

FDA Label Image

Figure (Humalogmix50 Kp Ifu 1 V3)

Figure (Humalogmix50 Kp Ifu 1 V3)
Humalog Mix 50/50 KwikPen label showing the product name with a red and white color scheme. The label notes it is an insulin lispro protamine and insulin lispro injectable suspension for single patient use. The pen device is blue with a dosage selector visible on the side, and no other markings or package size information is shown.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 2a V3)

Figure (Humalogmix50 Kp Ifu 2a V3)
Illustration labeled 'KwikPen Parts' showing components of the Humalog Mix50/50 injectable pen including the Pen Cap, Cap Clip, Rubber Seal, Cartridge Holder with visible dosage markings (60, 120, 180), Plunger, Pen Body with product label, Dose Indicator, Dose Window, and Dose Knob.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 2b V3)

Figure (Humalogmix50 Kp Ifu 2b V3)
An illustration diagram showing the parts of a pen needle for injection, labeled as Outer Needle Shield, Inner Needle Shield, Needle, and Paper Tab. The diagram specifies that needles are not included.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 3 V2)

Figure (Humalogmix50 Kp Ifu 3 V2)
An instructional illustration showing the removal of a blue pen cap from a white insulin pen, indicated by a left-pointing red arrow. This image likely depicts part of the usage instructions for the Humalog Mix50/50 insulin pen by Eli Lilly and Company.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 4 V2)

Figure (Humalogmix50 Kp Ifu 4 V2)
An instructional illustration showing a hand holding a vial or cartridge with an arrow pointing horizontally to the right, indicating a shaking or mixing motion. The image suggests how to properly prepare Humalog Mix50/50 insulin before use.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 5 V2)

Figure (Humalogmix50 Kp Ifu 5 V2)
An instructional diagram showing how to rotate the Humalog Mix50/50 insulin pen by turning the attached cartridge in a circular motion. The illustration includes a hand holding the pen with arrows indicating the direction of rotation of the cartridge.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 6 V1)

Figure (Humalogmix50 Kp Ifu 6 V1)
An instructional illustration showing a hand twisting the cap off a vial, with a red arrow indicating the direction to turn the cap.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 7 V1)

Figure (Humalogmix50 Kp Ifu 7 V1)
An instructional illustration showing a pen-type insulin device with a red arrow indicating the top section being twisted or removed. The image demonstrates how to open or prepare the insulin pen for use.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 8 V1)

Figure (Humalogmix50 Kp Ifu 8 V1)
An instructional diagram showing steps to handle needle shields for Humalog Mix50/50 insulin. It directs to keep the outer needle shield and throw away the inner needle shield before injection.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 9 V2)

Figure (Humalogmix50 Kp Ifu 9 V2)
An instructional illustration showing a magnified view of a dosage window on a Humalog Mix50/50 insulin pen, highlighting dosage numbers 1, 2, and 4 with an upward red arrow indicating the dial or dose adjustment mechanism.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 10 V2)

Figure (Humalogmix50 Kp Ifu 10 V2)
An instructional diagram depicting a hand holding a Humalog Mix50/50 insulin syringe, with the other hand adjusting the plunger. The image likely demonstrates how to properly prepare or measure insulin dose using the syringe.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 11 V2)

Figure (Humalogmix50 Kp Ifu 11 V2)
An instructional illustration showing a hand holding a Humalog Mix50/50 insulin pen with the other hand pressing the injection button. A zoomed inset highlights the appearance of a single drop of insulin at the needle tip, indicating proper priming or injection technique.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 12 V2)

Figure (Humalogmix50 Kp Ifu 12 V2)
Humalog Mix50/50 100 [iU]/mL insulin pen cartridge label showing a close-up of the dose window indicator set to a specific insulin dose. The label displays the dose selector on a blue pen device, manufactured by Eli Lilly and Company.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 13 V2)

Figure (Humalogmix50 Kp Ifu 13 V2)
An instructional illustration showing a hand holding an insulin pen with the dose selector window visible, indicating a selectable dose between 8 and 10 units. A red arrow points upward, suggesting how to adjust the dose on the Humalog Mix50/50 insulin pen.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 14 V2)

Figure (Humalogmix50 Kp Ifu 14 V2)
An instructional illustration showing a close-up view of a Humalog Mix50/50 insulin pen dose selector window. The dial displays numbers for dosing units with a red arrow pointing at the number 11, indicating how to set the dose.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 15 V2)

Figure (Humalogmix50 Kp Ifu 15 V2)
Illustration showing a close-up of a dosing window and adjustment dial on an insulin pen device. The dial displays numbers for dose selection, and the window shows a dose setting between 24 and 26 units. A red arrow points to the dosing window to highlight the selected dose.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 16 V1)

Figure (Humalogmix50 Kp Ifu 16 V1)
An instructional diagram showing front and back views of a human figure indicating recommended injection sites for Humalog Mix50/50. Marked areas include the abdomen, outer thighs, upper arms, and buttocks as suitable locations for injection.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 17 V1)

Figure (Humalogmix50 Kp Ifu 17 V1)
Illustration of a stopwatch showing a 5-second duration. The graphic emphasizes a short timed interval, likely indicating a wait or measurement period.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 18 V2)

Figure (Humalogmix50 Kp Ifu 18 V2)
An illustration showing a hand administering an injection into the upper thigh or buttock area of a seated person, demonstrating the injection technique likely related to Humalog Mix50/50 insulin delivery.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 20 V2)

Figure (Humalogmix50 Kp Ifu 20 V2)
An instructional illustration showing how to remove the cap from a Humalog Mix50/50 insulin syringe. The image depicts a hand pulling the cap off the syringe by pulling it backward, as indicated by a red arrow. The syringe is marked in units for dosage measurement.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 21 V2)

Figure (Humalogmix50 Kp Ifu 21 V2)
Illustration showing a hand holding an insulin pen with a partially removed red protective cap, highlighting the device used for administering Humalog Mix50/50 insulin, 100 units per mL.*
FDA Label Image

Figure (Humalogmix50 Kp Ifu 22 V2)

Figure (Humalogmix50 Kp Ifu 22 V2)
Instructional illustration showing how to remove the blue protective cap from a Humalog Mix50/50 insulin pen. The cap is depicted on the left side with an arrow indicating it should be pulled off to the left, exposing the insulin pen on the right side with dose window features visible.*
FDA Label Image

Package Carton – Humalog Mix50/50 Kwikpen 5ct (Humalogmix50 Kpen Carton 016 05)

Package Carton – Humalog Mix50/50 Kwikpen 5ct (Humalogmix50 Kpen Carton 016 05)
Label for Humalog Mix 50/50 KwikPen, an injectable suspension of insulin lispro protamine and insulin lispro, 100 units/mL strength. The package contains 5 prefilled pens, each with 3 mL. Manufactured by Eli Lilly and Company. The label notes it is for single patient use only, subcutaneous injection, and that needles are not included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.